BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fouladseresht H, Doroudchi M, Rokhtabnak N, Abdolrahimzadehfard H, Roudgari A, Sabetian G, Paydar S. Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19. Cytokine Growth Factor Rev 2021;58:32-48. [PMID: 33199179 DOI: 10.1016/j.cytogfr.2020.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wallukat G, Hohberger B, Wenzel K, Fürst J, Schulze-Rothe S, Wallukat A, Hönicke AS, Müller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021;4:100100. [PMID: 33880442 DOI: 10.1016/j.jtauto.2021.100100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
2 Lo Bianco G, Di Pietro S, Mazzuca E, Imburgia A, Tarantino L, Accurso G, Benenati V, Vernuccio F, Bucolo C, Salomone S, Riolo M. Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review. Front Pharmacol 2020;11:572168. [PMID: 33362541 DOI: 10.3389/fphar.2020.572168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lim KH, Yang S, Kim SH, Joo JY. Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer's Disease Patients Group Brain Using Genome-Wide Association Study Approach. Front Genet 2021;12:741175. [PMID: 34745215 DOI: 10.3389/fgene.2021.741175] [Reference Citation Analysis]
4 Li Y, Wei L, He L, Sun J, Liu N. Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.04.029] [Reference Citation Analysis]
5 Kimura T, Onitsuka C, Kawahara T, Fukuda Y, Homma T, Watanabe T, Ohsugi K, Ichikawa Y, Shono A, Kotani T, Sagara H. Extracorporeal Membrane Oxygenation for Secondary Organizing Pneumonia after Severe SARS-CoV-2 Infection: A Case Report. Medicina (Kaunas) 2021;57:1013. [PMID: 34684050 DOI: 10.3390/medicina57101013] [Reference Citation Analysis]
6 Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-chahhoud K, Kolahi A, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol 2022;12:785946. [DOI: 10.3389/fimmu.2021.785946] [Reference Citation Analysis]
7 Li XP, Huang X, Qin YM, Wu GY, Liang CC, Dai YJ, Zhang WN. SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers. Clin Transl Med 2021;11:e345. [PMID: 33634992 DOI: 10.1002/ctm2.345] [Reference Citation Analysis]
8 Heber S, Pereyra D, Schrottmaier WC, Kammerer K, Santol J, Rumpf B, Pawelka E, Hanna M, Scholz A, Liu M, Hell A, Heiplik K, Lickefett B, Havervall S, Traugott MT, Neuböck MJ, Schörgenhofer C, Seitz T, Firbas C, Karolyi M, Weiss G, Jilma B, Thålin C, Bellmann-weiler R, Salzer HJF, Szepannek G, Fischer MJM, Zoufaly A, Gleiss A, Assinger A. A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation. Front Cell Infect Microbiol 2022;11:795026. [DOI: 10.3389/fcimb.2021.795026] [Reference Citation Analysis]